Latest stories on LGND
Ligand Pharmaceuticals (LGND): Massive XOMA Acquisition Doubles The Royalty Book
Yahoo Top67 · bullishm&a
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma
StockTitan73 · bullishproduct/pr
Ligand Pharmaceuticals Highlights XOMA-Fueled Royalty Growth, $700M in Deployable Capital
Yahoo Finance67 · bullishm&a
Ligand to Participate in September Investor Conferences
GlobeNewswire55 · neutralgeneral
Stifel reiterates Buy on Ligand Pharma stock, $332 target
Investing.com Analyst Ratings61 · neutralanalyst
Ligand (LGND) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Breakout Watch: Savvy Investors Bet Millions On Royalty-Fueled Pharma Stock
Investors.com67 · bullishanalyst
Ligand Price Target Raised To 345 From 340 At Rbc Capital
The Fly56 · neutralanalyst
Ligand Pharmaceuticals Incorporated Q2 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
Ligand forecasts $9-$9.50 adjusted EPS in 2026 as XOMA deal adds about $0.50 in 2H 2026
Seeking Alpha67 · bullishearnings
Ligand Pharmaceuticals Incorporated (LGND) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Ligand Pharmaceuticals Incorporated 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Ligand Price Target Raised To 358 From 289 At H C Wainwright
The Fly67 · bullishanalyst
LIGAND PHARMACEUTICALS INC (LGNYZ) files 8-K
SEC 8-K50 · neutralgeneral
Ligand Reports Second Quarter 2026 Financial Results
StockTitan50 · neutralearnings
Ligand Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Oppenheimer raises Ligand Pharma stock price target to $326
Investing.com Analyst Ratings61 · neutralanalyst
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026
Investors.com67 · bullishgeneral
Ligand to Report Second Quarter 2026 Financial Results on August 6, 2026
Business Insider50 · neutralgeneral
Ligand resumed at buy at Citi with acquisition of XOMA Royalty
Seeking Alpha61 · neutralm&a
LIGAND PHARMACEUTICALS INC (LGNYZ) files 8-K
SEC 8-K50 · neutralgeneral
XOMA Royalty Announces Closing of Its Acquisition by Ligand
Business Insider62 · neutralm&a
XOMA Royalty Announces Closing of Its Acquisition by Ligand | XOMA Stock News
StockTitan50 · neutralm&a
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
Business Insider62 · neutralm&a